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Physiological and Psychological Correlates
of Fatigue in HIV Disease
Kenneth D. Phillips, PhD, RN
Richard L. Sowell, PhD, RN, FAAN
Michelle Rojas, MD
Abbas Tavakoli, DrPH
Laura J. Fulk, MS
Gregory A. Hand, PhD
Fatigue is a frequent symptom reported by per-
sons living with HIV disease and one that affects all
aspects of quality of life. To improve quality of care of
persons with HIV disease, it is important to address all
factors that contribute to fatigue. The purpose of this
study was to determine the associations of physiologi-
cal, psychological, and sociological factors with
fatigue in an HIV-infected population. With Piper’s
integrated fatigue model guiding selection, factors
examined in this study were hemoglobin, hematocrit,
CD4+ cell count, HIV-RNA viral load, total sleep
time, sleep quality, daytime sleepiness, HIV-related
symptoms, anxiety, depression, and perceived stress.
The sample (N = 79) for this descriptive correlational
study was recruited from a primary health care associ-
ation in South Carolina and consisted of 42 (53.2%)
HIV-infected women and 37 (46.8%) HIV-infected
men between the ages of 24 and 63 years (x = 39.9, s =
7.9). Of the participants, 70 (90%) were African
American, 5 (6%) were Caucasian, and 3 (4%) were
Hispanic. Using Pearson’s r, significant relationships
were observed between fatigue and sleep quality, day-
time sleepiness, HIV-related symptoms, state anxiety,
trait anxiety, depression, and perceived stress. Sleep
quality (F5,65 = 12.02, P = 0.0009), state anxiety
(F5,65 = 8.28, P = 0.0054), HIV-related symptoms
(F5,65 = 4.87, P = 0.0308), and depression (F5,65 =
7.31, P = 0.0087) retained significance in a 3-step,
backward stepwise elimination model and accounted
for 67% of the variance in fatigue. These findings
underscore the need for addressing psychosocial
stressors and sleep quality in developing effective care
for HIV-infected individuals who experience fatigue.
Key words: sleep, anxiety, perceived stress,
depression, HIV, fatigue
Fatigue, one of the most prevalent and distressful
symptoms of HIV infection (Barroso and Lynn 2002),
affects all aspects of an individual’s life. A multitude
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of factors may contribute to the fatigue experienced by
an HIV-infected individual. Understanding correlates
of fatigue allows nurses to plan and provide the holis-
tic care that is most appropriate for an HIV-infected
individual who is experiencing fatigue. The purpose of
this study was to determine the physiological, psycho-
logical, and sociological correlates of HIV-related
fatigue.
Theoretical Framework
Piper’s integrated fatigue model guided the selec-
tion of variables that were examined in this study
(Piper and others 1987; Piper 1989; see Fig. 1). Piper
has proposed that fatigue has temporal, sensory,
cognitive/mental, affective/emotional, behavioral,
and physiological dimensions and that it may arise
from physiological, psychological, or sociological eti-
ologies. Physiological, psychological, and sociologi-
cal factors theoretically linked with HIV-related fa-
tigue were examined in the present study.
Background
Fatigue has been defined as “a feeling of tiredness
that is influenced by circadian rhythm and occurs on a
continuum that has self-perceived energy or vigor at
its other end” (Grady and others 1998, p 227). Attrib-
utes of fatigue that are often identified include tired-
ness, lack of energy, exhaustion, lethargy, depression,
inability to concentrate, malaise, asthenia, boredom,
sleepiness, lack of motivation, and decreased mental
status (Winningham and others 1994; Rose and others
1998).
Fatigue is a debilitating symptom that almost al-
ways accompanies HIV/AIDS (Darko and others
1992; Hoover and others 1993; O’Dell and others
1996; Rondanelli and others 1997; Breitbart and oth-
ers 1998; Barroso 1999; Barroso and Lynn 2002;
Wollmann and others 2002; Barroso and others 2003)
and is sometimes experienced by otherwise asymp-
tomatic HIV-infected individuals (Hoover and others
1993; Enwonwu and others 1996; Grady and others
1998; Newshan and others 2002; Sullivan and others
2003). HIV-infected individuals have identified fa-
tigue as the most distressful symptom they must en-
dure (O’Brien and Pheifer 1993; Nokes and others
1994).
The prevalence of fatigue in HIV disease ranges
from 20% to 60% (Longo and others 1990; Darko and
others 1992; Hoover and others 1993; Vlahov and oth-
ers 1994; Breitbart and others 1998; Barroso 1999;
Sullivan and others 2003). During the acute phase of
the primary infection with HIV, fatigue occurs in most
persons. During the asymptomatic phase of the illness,
little or no fatigue is experienced. As HIV infection
progresses to AIDS, fatigue becomes a persistent, se-
vere symptom (Kaslow and others 1987; Lang and
others 1987; Groopman 1998). In a recent study, the
most frequently experienced symptoms reported by
HIV-infected individuals in an urban outpatient clinic
were fatigue, trouble sleeping, anxiety, and pain
(Newshan and others 2002).
Although research has focused on the etiology of
fatigue associated with HIV infection, the mecha-
nisms have remained elusive. A major obstacle is the
inclusion of various populations in the fatigue re-
search. Some researchers have demonstrated a gender
difference in fatigue. Women (67%) with AIDS have
been found to be more likely to report fatigue than men
(49%) with AIDS (Breitbart and others 1998; Sullivan
and others 2003). Intravenous drug users (IVDUs) re-
ported more fatigue than homosexual men who were
not IVDUs. Female IVDUs reported more fatigue than
60 BIOLOGICAL RESEARCH FOR NURSING Vol. 6, No. 1, July 2004
-Temporal
-Sensory
-Cognitive/ Mental
-Affective/ Emotional
-Behavioral
-Physiological
Life Event 
Patterns
Social Patterns
Environmental 
Patterns
Regulation /
Transmission 
Patterns
Psychological 
Patterns
Symptoms 
Patterns
Oxygenation 
Patterns
Treatment 
Patterns
Disease 
Patterns
Sleep / 
Wake 
Patterns
Activity / 
Rest 
Patterns
Energy and Energy 
Substrate Patterns
Accumulation of 
Metabolites
Innate Host 
Factors
Figure 1. Piper’s integrated fatigue model.
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male IVDUs (Brei tbar t and others 1998) .
Unsurprisingly, patients older than 35 years reported
more fatigue than did younger patients (Singh and
others 1997).
Fatigue has been reported in association with op-
portunistic infections (Cohen and others 1999), the
wasting syndrome (Macallan and others 1995), adre-
nal insufficiency (Piedrola and others 1996), thyroid
deficiency (Barroso 1999; Adinolfi 2001b), and
hypogonadism (Rabkin and others 2000). HIV-related
fatigue is often idiopathic (Carr and others 2000).
Fatigue and Medical Therapy
Fatigue is one of the most commonly reported ad-
verse reactions to antiretroviral medications (Duran
and others 2001; McMahon and others 2001; Kessler
and others 2002). Fatigue has been identified as a ma-
jor reason for nonadherence to highly active
antiretroviral therapy (HAART; Hagberg and Janson
2001; Molassiotis and others 2002; Monreal and oth-
ers 2002; Ostrow and others 2002). Reverse transcrip-
tase inhibitors and protease inhibitors are thought to
produce fatigue through their toxic effects on skeletal
muscle (Molassiotis and others 2002). Fatigue may
signal lactic acidosis, a serious and often fatal reaction
to nucleoside reverse transcriptase inhibitors (Carr and
others 2000; Delgado and others 2001; Anonymous
2002). A number of other approved and investiga-
tional drugs, such as interleukin-2, are known to lead
to increased fatigue in HIV-infected patients (Grady
and others 1998).
Fatigue and Anemia
Anemia is a common complication in persons with
HIV disease. Anemia affects approximately 3.4 mil-
lion Americans and is more common in women and
persons living in the South (National Center for Health
Statistics 1996). Fatigue is commonly reported by ane-
mic individuals (Moyle 2002) and is a cardinal symp-
tom in the diagnostic criteria for anemia. Profound
anemia has serious consequences for HIV-infected in-
dividuals in that it has been identified as a prognostic
indicator of HIV disease progression and death
(Moyle 2002). Although all classifications of anemia
are possible in HIV disease and must be differentiated
for treatment, the anemia of chronic illness is the most
common type of anemia (Phillips and Groër 2002).
Anemia adversely affects a range of the dimensions of
quality of life, most commonly mediated through
fatigue (Moyle 2002).
Clinically, the relationship between anemia and fa-
tigue is well accepted. However, some researchers
have been unable to show a clear association. For ex-
ample, a poor association was found between anemia
and fatigue in patients with different types of cancer
(Morant 1996), and no correlation was found between
anemia and fatigue in patients with advanced breast
cancer (Bruera and others 1989). O’Dell and col-
leagues (1996) found no significant relationships
between hemoglobin, hematocrit, albumin, or total
protein and fatigue in 20 HIV-positive men and con-
cluded that fatigue is more related to psychosocial fac-
tors than to anemia.
Fatigue and Insomnia
Darko and colleagues (1992) found that HIV-
infected subjects were more likely to report fatigue
than were noninfected subjects, and the HIV-infected
subjects were more likely to sleep longer and take
more naps. Lee and others (1999) examined the rela-
tionship of fatigue to sleep and activity patterns in HIV
disease. When compared to women with low fatigue
levels, women with high fatigue levels reported more
difficulty falling asleep, more awakening from night-
time sleep, poorer daytime functioning, and a higher
frequency of depressive symptoms.
Fatigue and CD4+ Cell Count
Contradictory findings have been reported regard-
ing the relationship between CD4+ cell count and fa-
tigue. Some researchers have reported a significant in-
verse relationship between CD4+ cell count and
fatigue (Darko and others 1992; O’Dell and others
1996; Walker and others 1997; Justice and others
1999); however, other researchers have found no rela-
tionship between CD4+ cell count and fatigue (de
Boer and others 1993; Perkins and others 1995;
Breitbart and others 1998; Barroso and others 2003;
Sullivan and others 2003). Lee and colleagues (1999)
reported significant inverse relationships between
CD4+ cell count and evening and morning fatigue in a
sample of HIV-infected women.
Phillips and others / Correlates of Fatigue 61
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Fatigue and HIV-RNA Viral Load
The relationship between HIV-RNA viral load and
fatigue remains uncertain. Lavreys and colleagues
(2002) examined the relationship between viral load
and the constitutional symptoms of primary HIV in-
fection prior to seroconversion and reported a signifi-
cant relationship between HIV-RNA viral load and fa-
tigue in that population. Other researchers have found
no relationship between fatigue and HIV-RNA viral
load (Ferrando and others 1998; Barroso and others
2003; Sullivan and others 2003).
Fatigue and Anxiety
Anxiety is a recognized correlate of fatigue in HIV/
AIDS (Groopman 1998). In a study of anxiety syn-
dromes and symptoms in 173 homosexual men with
AIDS, Sewell and colleagues (2000) found a positive
relationship between anxiety and fatigue. Other re-
searchers have reported similar relationships between
anxiety and fatigue in HIV disease (Barroso and others
2003).
Fatigue and Depression
Fatigue, depression, and weight loss are commonly
reported by HIV-infected individuals (Perkins and
others 1995). Health care providers may incorrectly
attribute these symptoms to disease progression and
fail to recognize their patients’underlying depression.
Unfortunately, it is difficult to sort out the relationship
between fatigue and depression (Walker and others
1997). Instruments used to measure depression com-
monly include somatic complaints/symptoms that are
similar to symptoms of fatigue. In addition, it is recog-
nized that fatigue is a major symptom of depression.
Significant relationships between depression and
fatigue have been reported in samples of HIV-positive
individuals (Perkins and others 1995; Walker and oth-
ers 1997; Breitbart and others 1998; Barroso and oth-
ers 2003). However, some researchers suggest that fa-
tigue in HIV-positive individuals may be a symptom of
underlying depression, whereas others suggest that it
is a physical symptom independent of mood. Ferrando
and colleagues (1998) investigated the prevalence of
fatigue in HIV illness and whether fatigue, being asso-
ciated with depression, independently affects physical
functioning and disability. These authors concluded
that although fatigue is associated with depression, it
does not seem to be merely a symptom of depression.
They also concluded that fatigue independently con-
tributes to physical limitations and disability and
should therefore be independently assessed and
treated. On the other hand, other studies have sug-
gested that fatigue is a manifestation of depression in
HIV illness (Perkins and others 1995; Lyketsos and
others 1996). Perkins and colleagues (1995) found
that depressive symptoms and major depression were
predictors of fatigue severity. In addition, Lyketsos
and colleagues (1996) found that fatigue and depres-
sive symptoms were closely associated across stages
of HIV illness and concluded that fatigue is most likely
a symptom of depression. Other researchers found a
close association between somatic symptoms of de-
pression and the number of AIDS-related diagnoses.
Almost 50% of their sample reported depressive
symptoms, and more than two-thirds of the subjects
reported fatigue (Kalichman and others 1995).
Therefore, the authors concluded that the assessment
of depression in individuals with HIV-related
symptoms should include only instruments without
somatic symptoms.
Fatigue and Perceived Stress
Using the Global Fatigue Index as a measure of fa-
tigue, Bormann and others (2001) reported a signifi-
cant direct correlation between perceived stress and
fatigue in a sample of HIV-infected individuals.
Breitbart and others (1998) found that HIV-infected
patients with fatigue report a greater degree of overall
psychological distress.
Fatigue and Quality of Life
Fatigue is strongly related to quality of life (Darko
and others 1992; Cleary and others 1993;
Winningham and others 1994; Darko, Mitler, and oth-
ers 1995; Yellen and others 1997; Breitbart and others
1998; Cunningham and others 1998; Groopman 1998;
Eller 2001). Fatigue can disrupt normal activities of
daily living (Winningham and others 1994), reduce
physical functioning (Winningham and others 1994;
Wilson and Cleary 1996; Fleishman and Crystal
1998), and reduce self-care activities (Hart and others
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1990; Rhodes and others 1988). Fatigue affects HIV-
infected individuals’ability to work and to take care of
themselves and their families, their physical and emo-
tional well-being, their enjoyment of life, and their
ability to be intimate with their partners (Groopman
1998). Fatigue may be the most important symptom in
an HIV-infected individual’s decision to discontinue
employment, and with that decision comes loss of
income and loss of health insurance (Darko and others
1992).
Summary
Although other researchers have demonstrated sig-
nificant relationships between these physiological and
psychological factors and fatigue, no report was found
in which all these variables were tested in a single
model. Understanding the variables that best predict
fatigue in HIV-infected individuals will allow health
care practitioners to develop plans of care that focus on
factors related to fatigue in HIV disease.
Method
Design
The data reported in this article were collected as
part of a study designed to examine physiological and
psychological correlates of fatigue in HIV disease. A
descriptive correlational design was used.
Sample
The sample for this report was recruited from a pri-
mary health care association in Columbia, South
Carolina. The sample consisted of 79 women and men
documented to be HIV infected. Individuals who were
18 years of age or older, able to read and understand
English at a 6th-grade level, and receiving health care
services at the primary health care association were in-
cluded in the study. No one was excluded on the basis
of gender or ethnicity.
Procedure
The Office for Research Protection at the Univer-
sity of South Carolina approved the study and its pro-
cedures prior to any data collection. Physicians at the
community health center referred potential partici-
pants to the study. Female research assistants who
were specially trained to provide full information re-
garding the research study and who signed a confiden-
tiality statement collected all data. Participants were
accessed at the time of their medical appointments for
periodic physical examinations and laboratory stud-
ies. A nurse directed individuals who were interested
in the study to a large, comfortable conference room in
the same building. The conference room provided
comfort, privacy, and easy access to the participants.
After receiving an informed consent statement and be-
ing fully informed of the nature and duration of the
study by the research assistant, individuals who agreed
to participate were asked to read and sign the informed
consent statement. In addition, they were asked to sign
a consent form that gave the primary health care prac-
tice permission to release the results of their laboratory
studies (complete blood count, HIV-RNA viral load,
and T helper cell [CD4+]) count to the researchers.
Data were collected using a structured question-
naire, which was completed on the same day the blood
for laboratory tests was drawn. The research assistant
was available to answer any questions the participants
might have about the study. After the participants com-
pleted the questionnaire, the research assistant placed
a wrist actigraph on their nondominant arms and in-
structed them in the care of the wrist actigraph. Partici-
pants were asked to wear the wrist actigraph continu-
ally for 3 days and nights. Participants and the research
assistants arranged an appointment to return the wrist
actigraphs. When they returned the wrist actigraphs,
the participants were paid $20 for taking part in the
study.
Instruments
Demographic data form. Participants were asked to
report standard demographic variables such as age and
race and HIV-related variables such as route of infec-
tion, stage of illness, symptoms, antiretroviral medica-
tions, and hematinic medications (particularly eryth-
ropoietin and iron).
Revised Piper Fatigue Scale (RPFS). The RPFS
was used to measure subjective fatigue. The RPFS
consists of 22 items that are numerically scaled from 0
(no fatigue) to 10 (high fatigue), and there are 5 items
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that give additional clinical information but are not
used in the scoring of fatigue. The RPFS yields a total
fatigue score and 4 subscale scores that reflect the
behavior/severity, affective meaning, sensory, and
cognitive/mood dimensions of fatigue (Piper 1989).
The 22 numerically scaled items are summed to give
the total fatigue score that was used in this study to
measure subjective fatigue. The total fatigue score is
divided by 22 to give a fatigue score that ranges from 0
to 10 (0 = no fatigue, 1 to 3 = mild fatigue, 4 to 6 = mod-
erate fatigue, and 7 to 10 = severe fatigue). The RPFS
demonstrates internal consistency with a Cronbach’s
α of 0.97. A higher score indicates greater subjective
fatigue (Piper and others 1998).
Hemoglobin, hematocrit, HIV-RNA viral load, and
CD4+ cell count. The results of the physiological vari-
ables were recorded directly from each individual’s
medical record. Hemoglobin and hematocrit were
used to measure the degree of anemia. HIV-RNA viral
load was measured using reverse transcriptase poly-
merase chain reaction.
Wrist actigraph. A MiniMotionLogger wrist acti-
graph (ambulatory monitoring) was used to measure
total sleep time. The wrist actigraph is a small device
about the size of a quarter that was attached to each
participant’s nondominant arm. The wrist actigraph
detects motion, which is converted to an electric signal
by a piezoelectric crystal. Data from the wrist acti-
graph are downloaded into a microcomputer for analy-
sis. An algorithm converts the signal into periods of
sleep and activity. The wrist actigraph allows the esti-
mation of the following parameters: (1) sleep-onset
latency, (2) wakening after sleep onset, (3) sleep dura-
tion, (4) percentage sleep, and (f) total sleep time. Sig-
nificant correlations have been reported between
polysomnography and the measurements of the wrist
actigraph on sleep-onset latency (r = 0.70, P <
0.0001), wake after sleep onset, (r = 0.25, P < 0.0001),
sleep duration, (r = 0.89, P < 0.0001), and total sleep
period (r = 0.90, P < 0.0001; Cole and others 1992).
These significant correlations support the validity of
this instrument to measure total sleep time. Total sleep
time was used as the measure of sleep activity.
Pittsburgh Sleep Quality Index (PSQI). The PSQI is
a self-report instrument that measures subjective sleep
quality. This instrument contains 19 self-report items.
The instrument yields a total sleep quality score and 7
component scores (sleep quality, sleep latency, sleep
duration, habitual sleep efficiency, sleep disturbances,
use of sleeping medication, and daytime dysfunction).
The total sleep quality score was used to measure sleep
quality. The total sleep quality score has a reported
internal consistency of 0.83 and a test-retest reliability
of 0.85. Validity of the PSQI is supported by its ability
to discriminate controls from depressives and individ-
uals with diagnosed sleep disorders. The findings of
the PSQI are supported by concurrent polysomno-
graphy. Possible scores for the total sleep quality scale
range from 0 to 21. “A PSQI global score greater than 5
indicates severe difficulties in at least 3 areas, or mod-
erate difficulties in more than 3 areas” (Buysse and
others 1989). A higher score indicates poorer sleep
quality (Buysse and others 1991).
Epworth Daytime Sleepiness Scale (ESS). The total
score for the ESS was used to measure daytime sleepi-
ness. This scale asks individuals to rate on a scale of 0
to 3 how likely they are to doze off or fall asleep in 8
specific situations. The total score for the ESS has a
reported reliability of 0.83 and a test-retest reliability
of 0.88 for patients. Possible scores can range from 0
to 24. A higher score indicates greater daytime sleepi-
ness (Johns 1991).
HIV-Related Symptom Scale (HSS). The HSS was
used to measure the frequency of HIV-related symp-
toms. This instrument is composed of 19 symptoms
(e.g., diarrhea, fever, weight loss, white patches in the
mouth) that are commonly experienced by HIV-
infected individuals. The HSS asked participants to
rate on a scale of 1 (no problem) to 4 (very much of a
problem) how much of a problem each of the symp-
toms had been for them during the past month. Two
of the symptoms on the HSS were fatigue and
weakness. These symptoms were not included in
the total score for these analyses because the out-
come measure was fatigue. The responses for each
of the remaining 17 items were summed to give a
total HIV-related symptom score. A higher score
indicated that an individual was experiencing
greater frequency of HIV-related symptoms. Reli-
ability was supported in this sample with a
Cronbach’s α of 0.87.
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Spielberger’s State-Trait Anxiety Inventory (STAI).
The STAI is a 40-item Likert-type instrument used to
measure state anxiety (transitory) and trait anxiety
(relatively stable anxiety proneness). There are 20
items for the state anxiety scale and 20 items for the
trait anxiety scale. The participants were asked to
respond to each of the items on a 4-point scale ranging
from 1 (not at all) to 4 (very much so). The state anxi-
ety scale has reported test-retest reliabilities ranging
from 0.16 to 0.92 and internal consistencies ranging
from 0.83 to 0.92. The trait anxiety scale has reported
test-retest reliabilities ranging from 0.73 to 0.92 and
internal consistencies ranging from 0.86 to 0.92. Con-
struct and concurrent validity of the STAI have been
supported in numerous studies. A higher score indi-
cates greater anxiety (Spielberger and others 1971).
Center for Epidemiological Studies Depression
Scale (CES-D). The CES-D is a 4-point, 20-item scale
that measures depressive symptoms. The participants
were asked to rate how often they had experienced the
depressive symptom represented by each of the 20
items in the past week. Responses range from 0 (not at
all to 1 day per week), 1 (1 to 2 days per week), 2 (3 to 4
days per week), to 3 (5 to 7 days per week). Possible
scores for the total scale range from 0 to 60. Reported
internal consistencies for the instrument have ranged
from 0.83 to 0.90. Concurrent and construct validity
have been supported in a number of studies. A higher
score indicates greater depressive symptoms (Radloff
1977). A cutoff point of greater than 16 is widely
accepted as diagnostic of clinical depression (Radloff
1977; Parikh and others 1988; Beekman and others
1997; Houston and others 2001, 2002).
Perceived Stress Scale (PSS). The PSS is a 30-item
instrument that measures perceived stress (Levenstein
and others 1993). The instrument yields a total score
for perceived stress and 7 subscale scores. The instru-
ment can be administered to collect data about general
perceived stress (in the past year or two) or recent per-
ceived stress (in the past month). In this study, the par-
ticipants were asked to consider the past month and to
rate each of the items on a scale of 1 (almost never) to 4
(usually). The instrument has a reported test-retest
reliability of 0.82 for the General Form, but the Recent
Form varied by a mean factor of 1.9 over 6 months.
Reported internal consistencies were greater than 0.90
for both forms of the PSS. The developers of the PSS
have reported concurrent and construct validity. The
total score was used to measure perceived stress in this
study. A higher score indicates greater perceived stress
(Levenstein and others 1993). The psychometric prop-
erties of the instruments used in this study are summa-
rized in Table 1.
Data Analysis
The data were entered by a research assistant and
verified by an independent observer. Frequencies and
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Table 1. Description of the Instruments Used
Instrument xa s Potential Range Actual Range 
Piper Fatigue Scale 3.9 2.8 0–10 0–9.9 0.98
Hemoglobin (mg/dL) 12.9 1.7 .NA 7.8–16.0 .NA
Hematocrit (%) 38.3 4.9 .NA 24.0–47.7 .NA
CD4+ cell count (cells/mm3) 412 268 .NA 8–1140 .NA
HIV-RNA viral load 38,577 83,621 .NA 0–516,000 .NA
Total sleep time (min)b 399.3 168.3 .NA 119.7–966.7 .NA
Pittsburgh Sleep Quality Index 12.3 3.9 0–21 5–21 0.77
Epworth Daytime Sleepiness Scale 8.4 5.9 0–24 0–22 0.84
HIV Symptom Distress Scale 26.2 8.6 17–68 17–50 0.87
Spielberger’s State Anxiety Inventory 40.9 13.6 20–80 20–78 0.92
Spielberger’s Trait Anxiety Inventory 45.2 11.4 20–80 20–74 0.91
Center for Epidemiological Studies–
Depression 22.3 11.3 0–60 1–47 0.87
Perceived Stress Scale 68.0 19.2 0–120 2–114 0.95
a. The mean, standard deviation, actual range, and α reported are from the present study.
b. Total sleep time obtained via wrist actigraph.
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percentages were calculated for each of the
sociodemographic variables. Reliabilities for each of
the research instruments were estimated using
Cronbach’s α reliability coefficient. Bivariate correla-
tions were calculated between fatigue and the theoreti-
cally selected variables. A P value < 0.05 was estab-
lished as the level of statistical significance for the
backward stepwise elimination model. Variables that
were significantly related to fatigue in the bivariate
correlations were entered into a backward stepwise
elimination model. Collinearity diagnostics were per-
formed for the variables in the full model. Statistical
power for the backward stepwise regression was
calculated to be 0.80 with a medium effect size in this
sample.
Results
All participants in this study were infected with
HIV. They were predominately African Americans
(n = 70), and 5 were Caucasian and 3 Hispanic. Forty-
two participants were women, and 37 were men. The
majority of the participants were single (n = 64). The
remaining 14 participants reported that they were part-
nered. The participants ranged in age from 24 to 63
years (x = 39.9, s = 7.8). Thirteen participants were
asymptomatic, 25 were symptomatic, and 18 had de-
veloped AIDS. The frequencies do not add to 79 in all
cases due to missing data points. Means, standard de-
viations, and missing data points are reported in Ta-
ble 2.
Fifty-two participants were receiving combination
antiretroviral therapy, and 24 (31.6%) were not receiv-
ing any antiretroviral therapy. An independent t test
was performed to test whether there was a difference in
the total fatigue scale between participants who were
receiving combination antiretroviral therapy and those
participants who were not taking any antiretroviral
medications. No significant difference was detected
(t = 0.50, P = 0.62).
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Table 2. Description of Fatigue Based on the Demographic Characteristics of the Sample
Characteristic Frequency % x Fatigue s
Gender
Female 42 46.8 3.8 2.8
Male 37 53.2 4.1 2.8
Race
African American 70 89.8 3.8 2.8
Caucasian 5 6.4 4.5 3.0
Hispanic 3 3.8 4.6 0.9
Missing 1
Partnership status
Single 64 82.1 3.8 2.9
Partnered or married 14 17.9 4.7 2.1
Missing 1
Stage of illness
Asymptomatic 13 23.2 3.0 3.0
Symptomatic 25 44.6 3.6 2.6
AIDS 18 32.2 3.7 2.7
Missing 23
Antiretroviral therapy
Yes 52 68.4 3.8 2.6
No 24 31.6 4.2 3.3
Missing 3
Fatigue
None (0) 17 22.1 0.2 0.3
Mild (1–3) 22 28.6 2.7 0.9
Moderate (4–6) 27 35.1 5.4 0.9
Severe (7–10) 11 14.3 8.4 0.9
Missing 2
NOTE: The revised Piper Fatigue Scale was used to obtain measures of subjective fatigue.
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Comorbidity was examined in this sample. Ten sub-
jects reported being treated for hypertension; 9 were
treated for depression; 8 were treated for gastro-
esophageal reflux disease; 5 participants were treated
for diabetes mellitus, all of whom received oral
hypoglycemics and 2 of whom received insulin; 2
were being treated for dyslipidemia; 3 were receiving
appetite stimulants; 25% of the sample was anemic,
with 8 men (21.6%) having a hemoglobin count less
than 14 g/dL and 12 women (28.6%) having a hemo-
globin count less than 12 g/dL, thus meeting the crite-
ria for anemia. Two participants reported taking eryth-
ropoietin, 5 participants took iron supplements, and 15
participants reported taking multiple vitamins.
Depression scores for this sample ranged from 1 to
47, with a mean of 22.3 ± 11.3. In this sample, 54 par-
ticipants (68.4%) scored greater than 16 on the CES-
D, which is consistent with clinical depression. There
was no gender difference in depression scores (inde-
pendent t test; t = 1.54, P = 0.13).
Description of Fatigue
In our sample of 79 HIV-infected men and women,
we found that 60 participants (77.9%) reported some
degree of fatigue, with 22 (28.6%) reporting mild fa-
tigue, 27 reporting moderate fatigue (35.1%), and 11
(14.3%) reporting severe fatigue (see Table 2).
No differences in total fatigue were observed be-
tween men and women (independent t test; t = 0.50, P
= 0.62). Likewise, no significant differences were ob-
served in the total fatigue score between participants
who were asymptomatic, symptomatic, or who had
progressed to AIDS (ANOVA; F2,52 = 0.28, P = 0.75).
Finally, no significant differences in fatigue were ob-
served between those who were taking protease inhib-
itors and those who were not taking protease inhibitors
(independent t test, t = 0.78, P = 0.45). (Refer to Table
2 for means and standard deviations.)
Bivariate Correlations
Relationships of the demographic variables with to-
tal fatigue were tested using Pearson’s coefficient of
correlation (Pearson’s r). No significant relationship
was found between age and total fatigue (Pearson’s
correlation coefficient; r = –0.19, P = 0.17). Signifi-
cant relationships were observed between fatigue and
sleep quality (r = 0.53, P < 0.0001), daytime sleepi-
ness (r = 0.33, P = 0.0039), HIV-related symptoms (r =
0.61, P < 0.0001), state anxiety (r = 0.71, P < 0.0001),
trait anxiety (r = 0.57, P <. 0.0001), depression (r =
0.65, P < 0.0001), and perceived stress (r = 0.71, P <
0.0001), as shown in Table 3.
Tests for Multiple Collinearity
Because multicollinearity issues are of concern
when multiple psychometric measurements are used
in regression analyses, collinearity diagnostics were
performed for each of the variables in the full model.
All variance inflation factors were <10, and the condi-
tion inflation factors were <30, indicating that
multicollinearity was not a problem for this model.
Backward Stepwise Elimination
Subsequently, independent variables (sleep quality,
daytime sleepiness, HIV-related symptoms, state anx-
iety, trait anxiety, depression, and perceived stress)
that demonstrated a significant association with the
dependent variable (fatigue) were entered into a back-
ward stepwise elimination equation. In a 3-step solu-
tion, trait anxiety and perceived stress fell out of the
model. Sleep quality, state anxiety, HIV-related symp-
toms, and depression retained statistical significance
and explained 67% of the variance in fatigue, as shown
in Table 4.
Discussion
The results from the present study indicate a high
prevalence of fatigue in a predominantly African
American population of HIV-infected individuals.
Our findings regarding the high prevalence of fatigue
in this sample of HIV-infected men and women are
consistent with those of previous researchers (Darko
and others 1992; Hoover and others 1993; O’Dell and
others 1996; Rondanelli and others 1997; Breitbart
and others 1998; Barroso 1999; Barroso and Lynn
2002; Wollmann and others 2002; Barroso and others
2003).
We found no significant relationships between fa-
tigue and gender, race, partnership status, or
antiretroviral therapy. The failure to find a gender dif-
ference in fatigue in HIV-infected individuals is incon-
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sistent with the findings of Breitbart and colleagues
(1998) and Sullivan and colleagues (2003). This may
be explained in part by the different methods that were
used in data collection. Sullivan and colleagues col-
lected data via retrospective chart reviews and in-
cluded only individuals who reported fatigue as the
primary reason for a health care visit, fatigue on more
than one health care visit, or fatigue that limited the pa-
tient in his or her employment or sport. Likewise, the
researchers acknowledged use of an instrument that
has a less sensitive case definition for fatigue than the
one we used. Breitbart and colleagues (1998) col-
lected their data to the advent of HAART, more of the
participants had progressed to AIDS, and they used a
dichotomous item to measure the presence of fatigue.
It is likely that the total score for the Piper Fatigue
Scale is a more sensitive measure of fatigue.
There were a number of physiological and psycho-
logical characteristics associated with self-reported
fatigue in the subject group. However, the highest
correlations with fatigue were found among psycho-
logical variables. A backward stepwise regression
emphasized the impact of both psychological and
physiological characteristics, as both types of vari-
ables were included in the model that was predictive of
fatigue in the subjects.
Fatigue is the most common clinical complaint of
HIV-infected individuals, with a prevalence range of
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Table 3. Bivariate Correlations among the Study Correlations Using Pearson’s r (n = 77)
Variable 1 2 3 4 5 6 7 8 9 10 11 12
1. Fatiguea
2. Hemoglobin 0.030
3. Hematocrit 0.001 0.977****
4. CD4+ cells 0.057 0.414** 0.450***
5. Viral load 0.249 –0.178 –0.166 –0.259
6. Total sleep
timeb –0.084 –0.232 0.243 –0.175 0.335*
7. Sleep qualityc 0.526**** –0.041 0.053 0.051 –0.028 –0.182
8. Daytime
sleepinessd 0.333** 0.149 0.093 –0.269 –0.023 –0.072 0.186
9. Symptomse 0.551**** –0.258* –0.320* –0.194 0.133 0.030 0.287* 0.335**
10. State anxietyf 0.706**** 0.004 0.013 –0.056 0.209 –0.097 0.423**** 0.175 0.515****
11. Trait anxietyg 0.568**** 0.076 0.043 0.005 0.107 –0.133 0.251* 0.221 0.475**** 0.744****
12. Depressionh 0.645**** 0.188 0.152 –0.062 0.208 –0.110 0.297** 0.366** 0.492**** 0.678**** 0.780****
13. Perceived
stressi 0.712**** 0.077 0.056 –0.068 0.163 –0.028 0.411*** 0.343** 0.543**** 0.772**** 0.801**** 0.803****
a. Revised Piper Fatigue Scale (total score).
b. Wrist actigraph.
c. Pittsburgh Sleep Quality Index (total score).
d. Epworth Daytime Sleepiness Scale.
e. HIV Symptom Distress Scale.
f. Spielberger’s State Anxiety Inventory.
g. Spielberger’s Trait Anxiety Inventory.
h. Center for Epidemiological Studies–Depression Scale.
i. Perceived Stress Scale.
*P < 0.05. **P < 0.01. ***P < 0.001. ****P < 0.0001.
Table 4. Backward Stepwise Regression Analysis Summary
for Variables Predicting Fatigue
Standard
Variable  Error  F P
Intercept –4.23 0.84 25.2 < 0.0001
Sleep quality 0.20 0.06 12.0 0.0016
State anxiety 0.06 0.03 8.3 0.0054
HIV-related symptoms 0.06 0.02 4.9 0.0308
Depression 0.07 0.03 7.3 0.0087
NOTE: R2 = 0.67; Model F5,65 = 31.66, P < 0.0001; N = 71.
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10% to 30% among asymptomatic patients and 40% to
50% among AIDS patients (Adinolfi 2001a, 2001b;
Sullivan and others 2003). Although fatigue is associ-
ated with deteriorating physical health, mental well-
being, and quality of life, it is also predictive of dimin-
ishing physical function (Ferrando and others 1998).
Fatigue affects the HIV-infected individual finan-
cially, as it generally leads to decreased vigor, lower
quality of work, and increased absenteeism (Darko
and others 1992; Darko, Mitler, and others 1998).
Although fatigue has a clear impact on the overall
quality of life of a large number of HIV-infected indi-
viduals, it is difficult to define and measure. Therefore,
the physiological and psychological characteristics re-
sponsible for feelings of fatigue have been elusive.
Finding the causes of fatigue is difficult because of the
likelihood that fatigue associated with HIV infection
is the result of a number of pathological conditions
that are constantly in flux. Not surprisingly, there is a
significant amount of conflicting data concerning the
relationships between fatigue and physiological and
psychological characteristics. For example, there are
conflicting reports of the association between fatigue
and CD4+ cell count. One study found an inverse rela-
tionship between level of fatigue and CD4+ count in
HIV-infected gay men (Walker and others 1997).
These authors suggest that this relationship may be
caused by exhaustion of the body from fighting infec-
tion during advanced stages of HIV. On the other hand,
3 other studies found no relationship between the 2
variables (Ferrando and others 1998; Barroso and
Lynn 2002; Sullivan and others 2003). Our findings
are in support of studies showing no correlations be-
tween measures of immune function and reported
symptoms of HIV illness (Rabkin and others 1991;
Perry and others 1992; de Boer and others 1993; Per-
kins and others 1995; Breitbart and others 1998;
Ferrando and others 1998; Barroso and others 2002;
Sullivan and others 2003).
One interesting outcome of the present study is the
very low prevalence of anemia in the subject group.
Anemia is a common physiological disturbance in
HIV infection, with up to 80% of the population expe-
riencing anemia at some point (Doweiko and
Groopman 1998). Fatigue is arguably the most com-
mon presenting symptom associated with anemia. The
anemic condition results from a number of mecha-
nisms including disrupted hematopoiesis, bone mar-
row infection, hemolysis, and antiviral therapy
(Groopman 1998). Unfortunately, although signifi-
cant technological discoveries have advanced HIV
treatment, there has been little change in the preva-
lence of anemia in the HIV-infected population
(Mocroft and others 1999). In the present study, only a
relatively small portion of the subjects, about 25%,
presented with anemia. This disproportionately low
number could be due to a number of factors. First, the
incidence of anemia rises along with the number of
symptoms and as the individual reaches AIDS status.
Our participant group consisted of primarily asymp-
tomatic ambulatory individuals. Second, the anemia
associated with HIV infection may be due to nutri-
tional deficiencies (Doweiko and Groopman 1998).
Since our subjects were recruited at a highly recog-
nized primary care facility with a specialization in
HIV infection, it is likely that the individuals’ con-
ditions, including nutritional status, were well managed.
With a range of 5 to 21 on the PSQI, all subjects in
our study reported pathological sleep disturbances.
Our data indicate that the subjects averaged approxi-
mately 6.7 ± 2.8 h of sleep per night. Although there
was a wide range of total sleep time and the average
appears to be in the low range, there was no correlation
between total sleep time and fatigue. However, both
sleep quality and daytime sleepiness were correlates
of fatigue. Furthermore, backward stepwise regres-
sion analysis indicates that sleep quality is 1 of the 4
determinants of fatigue in our subject population.
These findings would suggest that the feelings of fa-
tigue associated with HIV infection in our group are
likely due to altered sleep patterns rather than hours of
sleep. This possibility is supported by research from
Darko and associates (Darko, Miller, and others 1995;
Darko, Mitler, and others 1995; Darko and others
1998) indicating HIV-dependent changes in nocturnal
secretion of specific hormones that might contribute to
sleep pathologies other than insomnia. These hor-
monal changes included plasma levels of tumor necro-
sis factor–α and growth hormone, both of which have
been linked to sleep patterns and resulting sleep qual-
ity. A relationship has further been shown between
morning fatigue and measures related to sleep quality,
including duration of wake episodes during the night,
napping, and perception of sleep disturbance during
the past week. In addition, the number of awakenings
throughout the night predicted the severity of fatigue,
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and lower CD4+ cell counts were related to greater
daytime sleep and higher morning and evening fatigue
(Lee and others 1999). Thus, it appears that certain
physiological alterations observed in HIV illness
contribute to altered sleep patterns that could result in
feelings of fatigue during the day.
Physical symptoms of HIV infection also affect
sleep variables and showed a relatively high correla-
tion with fatigue in our study. Our subjects reported an
average score of 30.8 ± 10.2 (range = 17–58) out of a
possible 68 on the HSS. Many of these physical symp-
toms, such as pain, have been shown to contribute to
fatigue in the HIV-infected individual (Breitbart and
others 1998). Symptoms of HIV were included in the
regression model for determinants of fatigue in this
population of infected subjects. Very few studies have
been done using the HSS since it was recently devel-
oped. However, the items on the scale are valid; the
Cronbach’s α for the entire tool was 0.94.
Psychological factors have been proposed as the
primary mechanism for fatigue in HIV-positive indi-
viduals. In a study examining the relationship between
fatigue and physiological parameters, no significant
associations were found between hematocrit, hemo-
globin, total protein, and albumin. The authors con-
cluded that there is a stronger association between
fatigue and psychological parameters than between
fatigue and physiological parameters (O’Dell and oth-
ers 1996).
We found that a majority of the participants in our
study scored greater than 16 on the CES-D, which in-
dicates a high prevalence of clinical depression in this
sample. Some studies examining the prevalence of de-
pression in HIV patients reporting fatigue have not
supported the hypothesis that HIV-related fatigue is
associated with depression (Walker and others 1997;
Breitbart and others 1998). In our study, depression
and fatigue showed a relatively high correlation. De-
pression retained significance in the final backward
stepwise elimination model. We support the notion
that the level of depression is associated with the num-
ber of symptoms resulting from HIV infection. The
correlation between depression and fatigue may there-
fore be dependent on the HIV-related symptoms that
partially determine fatigue.
In the present study, both state and trait anxiety cor-
related with fatigue. Furthermore, state anxiety sur-
vived the backward stepwise regression analysis and
was included in the model of determinants of fatigue.
The significant relationships found between state anx-
iety, trait anxiety, and fatigue are consistent with find-
ings of prior research (Sewell and others 2000;
Barroso and others 2003). Interestingly, both state and
trait anxiety correlated with sleep quality and HIV-
related symptoms. Further investigation will be re-
quired to determine the relationship between anxiety,
sleep, and symptoms. However, since sleep quality is
partially dependent on the degree of physical limita-
tion (Gielen and others 2001) and on the individual’s
level of psychological distress (Breitbart and others
1998), to suggest a cyclical interaction of those 3 char-
acteristics that results in fatigue would not be too
speculative. This suggestion is supported by a study
of anxiety syndromes and symptoms in 173 homo-
sexual men with AIDS demonstrating a positive re-
lationship between anxiety and fatigue (Sewell and
others 2000).
In the present study, perceived stress was highly
correlated with fatigue; however, perceived stress did
not hold up in the final regression model when the
other variables were taken into account. Further re-
search is needed to determine whether the relationship
between perceived stress and fatigue may be mediated
by other factors. Perceived stress is not typically ex-
amined in fatigue research. Breitbart and others (1998)
found that HIV-infected patients with fatigue report a
greater degree of overall psychological distress, and a
number of studies have shown a higher level of the
stress hormone cortisol in the plasma of HIV-infected
individuals as compared to HIV-negative subjects
(Clerici and others 1997). It is well established that in-
creased unpredictability in a situation will increase
perceived stress and cortisol levels (Malarkey and oth-
ers 1995; Steptoe and others 1998; Atanackovic and
others 2002). It follows that an individual with a diag-
nosed HIV infection would have enhanced stress reac-
tivity to other stressors; in fact, hypercortisolemia is
characteristic in the asymptomatic stages of HIV in-
fection. The increased levels of cortisol are related to
increased arousal, decreased sleep, and reduced rapid
eye movement sleep (Born and others 1986). Cortisol
enhances HIV replication as well (Markham and oth-
ers 1986). Therefore, the association of perceived
stress and fatigue may be mediated by stress-
hormone-related sleep-quality disruption and other
factors related to increased viral load.
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Study Limitations
Although this study presents very useful informa-
tion, some limitations should be noted. First, the par-
ticipants for this study were recruited from 1 medical
practice in 1 geographic region, the southeastern
United States. The physicians in that medical practice
referred patients who met the study criteria to the re-
search study. Using this convenience sample may have
resulted in bias through self-selection. The
generalizability of the findings of this study is further
limited in that the sample was predominantly com-
posed of 1 racial group, African Americans. And fi-
nally, fatigue may be influenced by a number of
sociodemographic factors that were not collected as
part of this study.
Clinical Implications
Fatigue is underreported by patients and
undertreated by health care providers (Justice and oth-
ers 1999; Adinolfi 2001b; Curt and Johnston 2003). A
reason may be that HIV-infected patients and their
health care providers may not be giving adequate at-
tention to the symptom of fatigue (Groopman 1998).
Health care providers should reconsider whether their
communication skills are facilitative and should ques-
tion HIV-infected patients about all bothersome symp-
toms, such as fatigue, at each visit (Eller 2001). Health
care providers should also reassess their perception of
fatigue and their approach to treating fatigue
(Groopman 1998).
Thorough assessment of fatigue is the basis for
planning effective interventions for HIV-related fa-
tigue. That assessment should include its onset, dura-
tion, severity, factors that increase and decrease the
level of fatigue, self-care interventions tried by the pa-
tient, and the resolution of fatigue. Based on the find-
ings of our study, a thorough psychosocial assessment
is beneficial in helping the fatigued patient. A plan of
care that considers the whole patient (physiologic fac-
tors, roles and responsibilities of the patient, support
systems, and factors such as depression and anxiety) is
necessary to help the patient achieve an optimum level
of health. Fatigue level must be reevaluated at each
contact with the patient.
Implications for the Integrated Fatigue Model
Certainly, this study did not address the integrated
fatigue model in its entirety. However, the findings of
this study do support the multidimensional nature of
the fatigue associated with HIV disease and help to es-
tablish the need for considering sleep quality, anxiety,
HIV-related symptoms, and depression in the care of
HIV-infected women and men who are experiencing
fatigue.
Implications for Future Research
Although this study provides important informa-
tion about this sample, the descriptive, correlational
design does not allow for causal inference. An impor-
tant follow-up to this study would be to develop and
test an intervention targeting these factors to see if
such an intervention would decrease fatigue and im-
prove quality of life for HIV-infected individuals. In a
future intervention study, the sample should include a
greater percentage of individuals who are anemic and
who report significant levels of fatigue. The sample
was not adequate to detect fatigue due to anemia. Ob-
jective measures of fatigue would provide valuable
insight into metabolic causes.
Conclusion
In summary, the present study examined selected
physiological and psychological correlates of fatigue.
The results indicated that the physiological character-
istics of sleep quality, daytime sleepiness, and HIV-
related symptoms correlated with fatigue. The psy-
chological characteristics that correlated with fatigue
were state and trait anxiety, depression, and perceived
stress. A backward stepwise regression model indi-
cated that almost 70% of the variability in fatigue
could be explained in a model containing sleep quality,
state anxiety, HIV-related symptoms, and depression.
These data indicate that the high prevalence of fatigue
in the HIV-infected population is a multifactorial syn-
drome that includes both physiological and psycho-
logical correlates. The results also suggest that stress-
related factors probably contribute significantly to the
fatigue syndrome.
Phillips and others / Correlates of Fatigue 71
 at UNIV OF TENNESSEE on July 13, 2010 http://brn.sagepub.comDownloaded from 
References
Adinolfi A. 2001a. Assessment and treatment of HIV-related
fatigue. J Assoc Nurses AIDS Care 12 Suppl:29-34.
Adinolfi A. 2001b. The need for national guidelines to manage
fatigue in HIV-positive patients. J Assoc Nurses AIDS Care 12
Suppl:39-42.
Anonymous. 2002. Lactic acidosis and anti-retroviral drugs.
Prescrire Internationale 11:113-5.
Atanackovic D, Brunner-Weinzierl MC, Kroger H, Serke S, Deter
HC. 2002. Acute psychological stress simultaneously alters
hormone levels, recruitment of lymphocyte subsets, and pro-
duction of reactive oxygen species. Immunol Invest 31:73-91.
Barroso J. 1999. A review of fatigue in people with HIV infection.
J Assoc Nurses AIDS Care 10:42-9.
Barroso J, Carlson JR, Meynell J. 2003. Physiological and psycho-
logical markers associated with HIV-related fatigue. Clin Nurs
Res 12;49-68.
Barroso J, Lynn MR. 2002. Psychometric properties of the HIV-
Related Fatigue Scale. J Assoc Nurses AIDS Care 13:66-75.
Barroso J, Preisser JS, Leserman J, Gaynes BN, Golden RN, Evans
DN. 2002. Predicting fatigue and depression in HIV-positive
gay men. Psychosomatics 43:317-25.
Beekman AT, Deeg DJ, Van Limbeek J, Braam AW, De Vries MZ,
Van Tilburg W. 1997. Criterion validity of the Center for
Epidemiologic Studies Depression scale (CES-D): results from
a community-based sample of older subjects in the Nether-
lands. Psychol Med 27:231-5.
Bormann J, Shively M, Smith TL, Gifford AL. 2001. Measurement
of fatigue in HIV-positive adults: reliability and validity of the
Global Fatigue Index. J Assoc Nurses AIDS Care 12:75-83.
Born J, Kern W, Bieber K, Fehm-Wolfsdorf G, Schiebe M, Fehm
HL. 1986. Night-time plasma cortisol secretion is associated
with specific sleep stages. Biol Psychiatry 21:1415-24.
Breitbart W, McDonald MV, Rosenfeld B, Monkman ND, Passik
S. 1998. Fatigue in ambulatory AIDS patients. J Pain Symptom
Manage 15:159-67.
Bruera E, Brenneis C, Michaud M, Rafter J, Magnan A, Tennant A,
Hanson J, Macdonald RN. 1989. Association between asthenia
and nutritional status, lean body mass, anemia, psychological
status, and tumor mass in patients with advanced breast cancer.
J Pain Symptom Manage 4:59-63.
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ.
1989. The Pittsburgh Sleep Quality Index: a new instrument for
psychiatric practice and research. Psychiatry Res 28:193-213.
Buysse DJ, Reynolds CF III, Monk TH, Hoch CC, Yeager AL,
Kupfer DJ. 1991. Quantification of subjective sleep quality in
healthy elderly men and women using the Pittsburgh Sleep
Quality Index (PSQI). Sleep 14:331-8.
Carr A, Miller J, Law M, Cooper DA. 2000. A syndrome of
lipoatrophy, lactic acidaemia and liver dysfunction associated
with HIV nucleoside analogue therapy: contribution to protease
inhibitor-related lipodystrophy syndrome. AIDS 14:F25-32.
Cleary PD, Fowler FJ Jr, Weissman J, Massagli MP, Wilson I,
Seage GR III, Gatsonis C, Epstein A. 1993. Health-related
quality of life in persons with acquired immune deficiency syn-
drome. Med Care 31:569-80.
Clerici M, Trabattoni D, Piconi S, Fusi ML, Ruzzante S, Clerici C,
Villa ML. 1997. A possible role for the cortisol/anticortisols
imbalance in the progression of human immunodeficiency
virus. Psychoneuroendocrinology 22 Suppl 1:S27-31.
Cohen PT, Sande MA, Volberding PA. 1999. The AIDS knowledge
base: a textbook on HIV disease from the University of Califor-
nia, San Francisco and San Francisco General Hospital. 3rd ed.
Philadelphia: Lippincott, Williams & Wilkins.
Cole RJ, Kripke DF, Gruen W, Mullaney DJ, Gillin JC. 1992.
Automatic sleep/wake identification from wrist activity. Sleep
15:461-9.
Cunningham WE, Shapiro MF, Hays RD, Dixon WJ, Visscher BR,
George WL, Ettl MK, Beck CK. 1998. Constitutional symp-
toms and health-related quality of life in patients with symp-
tomatic HIV disease. Am J Med 104;129-36.
Curt G, Johnston PG. 2003. Cancer fatigue: the way forward.
Oncologist 8 Suppl 1:27-30.
Darko DF, McCutchan JA, Kripke DF, Gillin JC, Golshan S. 1992.
Fatigue, sleep disturbance, disability, and indices of progres-
sion of HIV infection. Am J Psychiatry 149:514-20.
Darko DF, Miller JC, Gallen C, White J, Koziol J, Brown SJ, and
others. 1995. Sleep electroencephalogram delta-frequency
amplitude, night plasma levels of tumor necrosis factor alpha,
and human immunodeficiency virus infection. Proc Natl Acad
Sci U S A 92:12080-4.
Darko DF, Mitler MM, Henriksen SJ. 1995. Lentiviral infection,
immuneresponsepeptidesandsleep.AdvNeuroimmunol5:57-77.
Darko DF, Mitler MM, Miller JC. 1998. Growth hormone, fatigue,
poor sleep, and disabi l i ty in HIV infect ion.
Neuroendocrinology 67:317-24.
de Boer JB, van Dam FS, Sprangers MA, Frissen PH, Lange JM.
1993. Longitudinal study on the quality of life of symptomatic
HIV-infected patients in a trial of zidovudine versus zidovudine
and interferon-alpha. AIDS 7:947-53.
Delgado J, Harris M, Tesiorowski A, Montaner JS. 2001. Symp-
tomatic elevations of lactic acid and their response to treatment
manipulation in human immunodeficiency virus-infected per-
sons: a case series. Clin Infect Dis 33:2072-4.
Doweiko JP, Groopman JE. 1998. Hamtologic manifestations of
HIV infection. In Wormser GP, editor. AIDS and other mani-
festations of HIV infection. Philadelphia: Lippincott-Raven. p
541-57.
Duran S, Spire B, Raffi F, Walter V, Bouhour D, Journot V,
Cailleton V, Leport C, Moatti JP. 2001. Self-reported symp-
toms after initiation of a protease inhibitor in HIV-infected
patients and their impact on adherence to HAART. HIV Clin
Trials 2:38-45.
Eller LS. 2001. Quality of life in persons living with HIV. Clin
Nurs Res 10:401-23.
Enwonwu CO, Meeks VI, Sawiris PG. 1996. Elevated cortisol lev-
els in whole saliva in HIV infected individuals. Eur J Oral Sci
104:322-4.
72 BIOLOGICAL RESEARCH FOR NURSING Vol. 6, No. 1, July 2004
 at UNIV OF TENNESSEE on July 13, 2010 http://brn.sagepub.comDownloaded from 
Ferrando S, Evans S, Goggin K, Sewell M, Fishman B, Rabkin J.
1998. Fatigue in HIV illness: relationship to depression, physi-
cal limitations, and disability. Psychosom Med 60:759-64.
Fleishman JA, Crystal S. 1998. Functional status transitions and
survival in HIV disease: evidence from the AIDS Costs and
Service Utilization Survey. Med Care 36:533-43.
Gielen AC, McDonnell KA, Wu AW, O’Campo P, Faden R. 2001.
Quality of life among women living with HIV: the importance
violence, social support, and self care behaviors. Soc Sci Med
52:315-22.
Grady C, Anderson R, Chase GA. 1998. Fatigue in HIV-infected
men receiving investigational interleukin-2. Nurs Res 47:227-
34.
Groopman JE. 1998. Fatigue in cancer and HIV/AIDS. Oncology
(Huntingt) 12:335-44.
Hagberg L, Janson GL. 2001. Clinical and laboratory signs of
mitochondrial dysfunction secondary to nucleoside analogue
antiretroviral therapy are reversible. Scand J Infect Dis 33:558.
Hart LK, Freel MI, Milde FK. 1990. Fatigue. Nurs Clin North Am
25:967-76.
Hoover DR, Saah AJ, Bacellar H, Murphy R, Visscher B, Ander-
son R, Kaslow RA. 1993. Signs and symptoms of “asymptom-
atic” HIV-1 infection in homosexual men. Multicenter AIDS
Cohort Study. J Acquir Immune Defic Syndr 6:66-71.
Houston TK, Cooper LA, Ford DE. 2002. Internet support groups
for depression: a 1-year prospective cohort study. Am J Psychi-
atry 159:2062-8.
Houston TK, Cooper LA, Vu HT, Kahn J, Toser J, Ford DE. 2001.
Screening the public for depression through the Internet.
Psychiatr Serv 52:362-7.
Johns MW. 1991. A new method for measuring daytime sleepi-
ness: the Epworth sleepiness scale. Sleep 14:540-5.
Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA. 1999.
Sensitivity, specificity, reliability, and clinical validity of pro-
vider-reported symptoms: a comparison with self-reported
symptoms. Outcomes Committee of the AIDS Clinical Trials
Group. J Acquir Immune Defic Syndr 21:126-33.
Kalichman SC, Sikkema KJ, Somlai A. 1995. Assessing persons
with human immunodeficiency virus (HIV) infection using the
Beck Depression Inventory: disease processes and other poten-
tial confounds. J Pers Assess 64:86-100.
Kaslow RA, Phair JP, Friedman HB, Lyter D, Solomon RE, Dudley
J, Polk BF, Blackwelder W. 1987. Infection with the human
immunodeficiency virus: clinical manifestations and their rela-
tionship to immune deficiency. A report from the Multicenter
AIDS Cohort Study. Ann Intern Med 107:474-80.
Kessler HA, Johnson J, Follansbee S, Sension MG, Mildvan D,
Sepulveda GE, Bellos NC, Hetherington SV. 2002. Abacavir
expanded access program for adult patients infected with
human immunodeficiency virus type 1. Clin Infect Dis 34:535-
42.
Lang W, Anderson RE, Perkins H, Grant RM, Lyman D,
Winkelstein W Jr, Royce R, Levy JA. 1987. Clinical, immuno-
logic, and serologic findings in men at risk for acquired immu-
nodeficiency syndrome. The San Francisco Men’s Health
Study. JAMA 257:326-30.
Lavreys L, Baeten JM, Overbaugh J, Panteleeff DD, Chohan BH,
Richardson BA, Mandaliya K, Ndinya-Achola JO, Kreiss JK.
2002. Virus load during primary Human Immunodeficiency
Virus (HIV) type 1 infection is related to the severity of acute
HIV illness in Kenyan women. Clin Infect Dis 35:77-81.
Lee KA, Portillo CJ, Miramontes H. 1999. The fatigue experience
for women with human immunodeficiency virus. J Obstet
Gynecol Neonatal Nurs 28:193-200.
Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C,
Andreoli A. 1993. Development of the Perceived Stress Ques-
tionnaire: a new tool for psychosomatic research. J Psychosom
Res 37:19-32.
Longo MB, Spross JA, Locke AM. 1990. Identifying major con-
cerns of persons with acquired immunodeficiency syndrome: a
replication. Clin Nurse Spec 4:21-6.
Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing
EG, Triesman GJ. 1996. Changes in depressive symptoms as
AIDS develops. The Multicenter AIDS Cohort Study. Am J
Psychiatry 153:1430-7.
Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Cow-
ard WA, Sawyer MB, McManus TJ, Griffin GE. 1995. Energy
expenditure and wasting in human immunodeficiency virus
infection. N Engl J Med 333:83-8.
Malarkey WB, Pearl DK, Demers LM, Kiecolt-Glaser JK, Glaser
R. 1995. Influence of academic stress and season on 24-hour
mean concentrations of ACTH, cortisol, and beta-endorphin.
Psychoneuroendocrinology 20:499-508.
Markham PD, Salahuddin SZ, Veren K, Orndorff S, Gallo RC.
1986. Hydrocortisone and some other hormones enhance the
expression of HTLV-III. Int J Cancer 37:67-72.
McMahon D, Lederman M, Haas DW, Haubrich R, Stanford J,
Cooney E, Horton J, Kelleher D, Ross L, Cutrell A, and others.
2001. Antiretroviral activity and safety of abacavir in combina-
tion with selected HIV-1 protease inhibitors in therapy-naive
HIV-1-infected adults. Antivir Ther 6:105-14.
Mocroft A, Kirk O, Barton SE, Dietrich M, Proenca R,
Colebunders R, Pradier C, d’Arminio Monteforte A,
Ledergerber B, Lundgren JD. 1999. Anaemia is an independent
predictive marker for clinical prognosis in HIV-infected
patients from across Europe. EuroSIDA Study Group. AIDS
13:943-50.
Molassiotis A, Nahas-Lopez V, Chung WY, Lam SW, Li CK, Lau
TF. 2002. Factors associated with adherence to antiretroviral
medication in HIV-infected patients. Int J STD AIDS 13:301-
10.
Monreal MT, da Cunha RV, Trinca LA. 2002. Compliance to
antiretroviral medication as reported by AIDS patients assisted
at the University Hospital of the Federal University of Mato
Grosso do Sul. Braz J Infect Dis 6:8-14.
Morant R. 1996. Asthenia: an important symptom in cancer
patients. Cancer Treat Rev 22 Suppl A:117-22.
Moyle G. 2002. Anaemia in persons with HIV infection: prognos-
tic marker and contributor to morbidity. AIDS Rev 4:13-20.
National Center for Health Statistics. 1996. Vital and health statis-
tics series 10, number 200: current estimates from the national
Phillips and others / Correlates of Fatigue 73
 at UNIV OF TENNESSEE on July 13, 2010 http://brn.sagepub.comDownloaded from 
74 BIOLOGICAL RESEARCH FOR NURSING Vol. 6, No. 1, July 2004
health survey, 1996. Atlanta (GA): Centers for Disease Control
and Prevention.
Newshan G, Bennett J, Holman S. 2002. Pain and other symptoms
in ambulatory HIV patients in the age of highly active anti-
retroviral therapy. J Assoc Nurses AIDS Care 13:78-83.
Nokes KM, Wheeler K, Kendrew J. 1994. Development of an HIV
assessment tool. Image J Nurs Sch 26:133-8.
O’Brien ME, Pheifer WG. 1993. Physical and psychosocial nurs-
ing care for patients with HIV infection. Nurs Clin North Am
28:303-16.
O’Dell MW, Meighen M, Riggs RV. 1996. Correlates of fatigue in
HIV infection prior to AIDS: a pilot study. Disabil Rehabil
18:249-54.
Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable
PA, Jacobson LP, Strathdee SA. 2002. Attitudes towards highly
active antiretroviral therapy are associated with sexual risk tak-
ing among HIV-infected and uninfected homosexual men.
AIDS 16:775-80.
Parikh RM, Eden DT, Price TR, Robinson RG. 1988. The sensitiv-
ity and specificity of the Center for Epidemiologic Studies
Depression Scale in screening for post-stroke depression. Int J
Psychiatry Med 18:169-81.
Perkins DO, Leserman J, Stern RA, Baum SF, Liao D, Golden RN,
Evans DL. 1995. Somatic symptoms and HIV infection: rela-
tionship to depressive symptoms and indicators of HIV disease.
Am J Psychiatry 152:1776-81.
Perry S, Fishman B, Jacobsberg L, Frances A. 1992. Relationships
over 1 year between lymphocyte subsets and psychosocial vari-
ables among adults with infection by human immunodefi-
ciency virus. Arch Gen Psychiatry 49:396-401.
Phillips KD, Groer M. 2002. Differentiation and treatment of ane-
mia in HIV disease. J Assoc Nurses AIDS Care 13:47-68.
Piedrola G, Casado JL, Lopez E, Moreno A, Perez-Elias MJ,
Garcia-Robles R. 1996. Clinical features of adrenal insuffi-
ciency in patients with acquired immunodeficiency syndrome.
Clin Endocrinol 45:97-101.
Piper BF. 1989. Fatigue. In: Funk SG, Tournquist EM, Champagne
L, Copp A, Wiese RA, editors. Key aspects of comfort: man-
agement of pain, fatigue, and nausea. New York: Springer. p
199-208.
Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM.
1998. The revised Piper Fatigue Scale: psychometric evalua-
tion in women with breast cancer. Oncol Nurs Forum 25:677-
84.
Piper BF, Lindsey AM, Dodd MJ. 1987. Fatigue mechanisms in
cancer patients: developing nursing theory. Oncol Nurs Forum
14:17-23.
Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R. 2000. DHEA treat-
ment for HIV+ patients: effects on mood, androgenic and ana-
bolic parameters. Psychoneuroendocrinology 25:53-68.
Rabkin JG, Williams JB, Remien RH, Goetz R, Kertzner R,
Gorman JM. 1991. Depression, distress, lymphocyte subsets,
and human immunodeficiency virus symptoms on two occa-
sions in HIV-positive homosexual men. Arch Gen Psychiatry
48:111-9.
Radloff LS. 1977. The CES-D Scale: a self-report depression scale
for research in the general population. Applied Psychological
Measurement 1:385-401.
Rhodes VA, Watson PM, Hanson BM. 1988. Patients’descriptions
of the influence of tiredness and weakness on self-care abili-
ties. Cancer Nurs 11:186-94.
Rondanelli M, Solerte SB, Fioravanti M, Scevola D, Locatelli M,
Minoli L, Ferrari E. 1997. Circadian secretory pattern of
growth hormone, insulin-like growth factor type I, cortisol,
adrenocorticotropic hormone, thyroid-stimulating hormone,
and prolactin during HIV infection. AIDS Res Hum Retro-
viruses 13:1243-9.
Rose L, Pugh LC, Lears K, Gordon DL. 1998. The fatigue experi-
ence: persons with HIV infection. J Adv Nurs 28:295-304.
Sewell MC, Goggin KJ, Rabkin JG, Ferrando SJ, McElhiney MC,
Evans S. 2000. Anxiety syndromes and symptoms among men
with AIDS: a longitudinal controlled study. Psychosomatics
41:294-300.
Singh N, Squier C, Sivek C, Wagener MM, Yu VL. 1997. Psycho-
logical stress and depression in older patients with intravenous
drug use and human immunodeficiency virus infection: impli-
cations for intervention. Int J STD AIDS 8:251-5.
Spielberger CD, Gorsuch F, Lushene R. 1971. STAI manual for S-
T-A-I (“self-evaluation questionnaire”). Palo Alto (CA): Con-
sulting Psychologists Press.
Steptoe A, Wardle J, Lipsey Z, Mills R, Oliver G, Jarvis M,
Kirschbaum C. 1998. A longitudinal study of work load and
variations in psychological well-being, cortisol, smoking, and
alcohol consumption. Ann Behav Med 20:84-91.
Sullivan PS, Dworkin MS, the Adult and Adolescent Spectrum of
HIV Disease Investigators. 2003. Prevalence and correlates of
fatigue among persons with HIV infection. J Pain Symptom
Manage 25:329-33.
Vlahov D, Munoz A, Solomon L, Astemborski J, Lindsay A,
Anderson J, Galai N, Nelson KE. 1994. Comparison of clinical
manifestations of HIV infection between male and female
injecting drug users. AIDS 8:819-23.
Walker K, McGown A, Jantos M, Anson J. 1997. Fatigue, depres-
sion, and quality of life in HIV-positive men. J Psychosoc Ment
Health Serv 35:32-40.
Wilson IB, Cleary PD. 1996. Clinical predictors of functioning in
persons with acquired immunodeficiency syndrome. Med Care
34:610-23.
Winningham ML, Nail LM, Burke MB, Brophy L, Cimprich B,
Jones LS, Pickard-Holley S, Rhodes V, St. Pierre B, Beck S,
and others. 1994. Fatigue and the cancer experience: the state
of the knowledge. Oncol Nurs Forum 21:23-36.
Wollmann T, Barroso J, Monton F, Nieto A. 2002. Neuropsycho-
logical test performance of patients with Friedreich’s ataxia. J
Clin Exp Neuropsychol 24:677-86.
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. 1997.
Measuring fatigue and other anemia-related symptoms with
the Functional Assessment of Cancer Therapy (FACT) mea-
surement system. J Pain Symptom Manage 13:63-74.
 at UNIV OF TENNESSEE on July 13, 2010 http://brn.sagepub.comDownloaded from 
